Literature DB >> 18355378

Novel concepts in the diagnosis, pathophysiology and management of idiopathic megabowel.

M A Gladman1, C H Knowles.   

Abstract

A proportion of patients with intractable constipation have persistent dilatation of the bowel, which in the absence of an organic cause is termed idiopathic megabowel (IMB). Whilst uncommon, this condition results in considerable morbidity. Traditional methods of identifying such patients are associated with inherent methodological limitations with anorectal manometry and contrast studies overestimating and underestimating the prevalence of the condition, respectively. Recently, controlled, pressure-based distension during fluoroscopic imaging has allowed more accurate identification of patients on the basis of a rectal diameter > 6.3 cm at the minimum distension pressure. Histopathological abnormalities of all three final effectors of sensorimotor function have been reported, although it remains unclear whether these changes are primary, secondary or epiphenomic. Physiological abnormalities of sensorimotor function, namely impaired perception of rectal distension and delayed colonic transit are well documented in patients with IMB. Further, the recent demonstration of two subgroups of patients, defined on the basis of rectal compliance, suggests the possibility that they differ pathophysiologically, although the clinical relevance of this distinction is uncertain. Surgery is performed when conservative therapy is ineffective or poorly tolerated. Numerous procedures have been attempted with variable success rates and significant mortality and morbidity. Surgery should preferably be performed in specialist centres given the relative infrequency with which such patients are encountered, and that they require comprehensive clinical, psychological and physiological evaluation preoperatively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355378     DOI: 10.1111/j.1463-1318.2007.01457.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  8 in total

1.  Reaction to Koppen et al., 'Assessing colonic anatomy normal values based on air contrast enemas in children younger than 6 years'.

Authors:  Michael D Levin
Journal:  Pediatr Radiol       Date:  2018-06-30

2.  Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.

Authors:  Christian Breuer; Jun Oh; Gerhard-J Molderings; Michael Schemann; Birgit Kuch; Ertan Mayatepek; Rüdiger Adam
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

3.  Nationwide survey on adult type chronic intestinal pseudo-obstruction in surgical institutions in Japan.

Authors:  Tadahiko Masaki; Kenichi Sugihara; Atsushi Nakajima; Tetsuichiro Muto
Journal:  Surg Today       Date:  2012-01-12       Impact factor: 2.549

4.  Diagnosis of colonic dysmotility associated with autonomic dysfunction in patients with chronic refractory constipation.

Authors:  Lijun Liu; Natalija Milkova; Sharjana Nirmalathasan; M Khawar Ali; Kartik Sharma; Jan D Huizinga; Ji-Hong Chen
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

5.  The correlation between diverticulosis and redundant colon.

Authors:  Tahleesa Cuda; Ronny Gunnarsson; Alan de Costa
Journal:  Int J Colorectal Dis       Date:  2017-09-20       Impact factor: 2.571

6.  An unusual cause of idiopathic megacolon in a juvenile: A case report.

Authors:  Yinghua Liu; Zhibao Lv; Weijue Xu; Jiangbin Liu; Xiong Huang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 7.  The chronic gastrointestinal manifestations of Chagas disease.

Authors:  Nilce Mitiko Matsuda; Steven M Miller; Paulo R Barbosa Evora
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 8.  Symptoms and diagnostic criteria of acquired Megacolon - a systematic literature review.

Authors:  Tahleesa Cuda; Ronny Gunnarsson; Alan de Costa
Journal:  BMC Gastroenterol       Date:  2018-01-31       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.